Dishman Carbogen Amcis · NSE: DCAL · BSE: 540701
Q3 FY21 results · Oct–Dec 2020
Dishman Carbogen Amcis reported revenue from operations of ₹468.56 crore (down 13.6% from Q3 FY20) and net loss of ₹16.07 crore for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 468.56 | 542.28 | −13.6% | 439.48 | +6.6% |
| Other income | 8.95 | 8.84 | +1.2% | 14.94 | −40.1% |
| Total income | 477.51 | 551.12 | −13.4% | 454.42 | +5.1% |
| Profit before tax | (21.88) | 50.68 | Turned loss | 3.97 | Turned loss |
| Net profit for the period | (16.07) | 32.85 | Turned loss | 7.38 | Turned loss |
| EPS, basic (₹) | (1.02) | 2.04 | Turned loss | 0.47 | Turned loss |
| Net margin (%) | -3.4 | 6.1 | 1.7 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 60.95 | 117.68 | −48.2% | 30.53 | +99.6% |
| Other income | 19.23 | 25.36 | −24.2% | 33.58 | −42.7% |
| Total income | 80.18 | 143.04 | −43.9% | 64.11 | +25.1% |
| Profit before tax | (41.15) | (0.89) | Loss widened | (33.03) | Loss widened |
| Net profit for the period | (27.01) | (2.20) | Loss widened | (18.25) | Loss widened |
| EPS, basic (₹) | (1.72) | (0.14) | Loss widened | (1.16) | Loss widened |
| Net margin (%) | -44.3 | -1.9 | -59.8 |
Consolidated
- Filed with BSE
- 12 Feb 2021, 16:47 IST
- Board meeting
- 11 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Feb 2021, 16:47 IST
- Board meeting
- 11 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE